HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
about
Exome sequencing identifies a mutation in the ACTN2 gene in a family with idiopathic ventricular fibrillation, left ventricular noncompaction, and sudden deathManagement of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countriesGenetics of inherited primary arrhythmia disordersSudden unexplained death in infants and children: the role of undiagnosed inherited cardiac conditionsEmerging directions in the genetics of atrial fibrillationArrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular diseaseUse of contemporary genetics in cardiovascular diagnosisRecent advances in genetic testing and counseling for inherited arrhythmiasGenetics of Brugada syndromeClinical and Mechanistic Insights Into theĀ Genetics of CardiomyopathyThe Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic TargetsChannelopathies - emerging trends in the management of inherited arrhythmias2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theThe ARVD/C genetic variants database: 2014 updateThe genetics of dilated cardiomyopathy: a prioritized candidate gene study of LMNA, TNNT2, TCAP, and PLNA novel arginine to tryptophan (R144W) mutation in troponin T (cTnT) gene in an indian multigenerational family with dilated cardiomyopathy (FDCM)TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVTThe new kids on the block of arrhythmogenic disorders: Short QT Syndrome and early repolarization.Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationInherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy.Update on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C).Sudden cardiac death in children (1-18 years): symptoms and causes of death in a nationwide setting.Risk stratification and treatment of brugada syndrome.[Ion channel diseases in children].Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndromeA Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.Novel SCN10A variants associated with Brugada syndrome.Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.The Diagnosis, Risk Stratification, and Treatment of Brugada SyndromeArrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis.Cardiac magnetic resonance imaging after ventricular tachyarrhythmias increases diagnostic precision and reduces the need for family screening for inherited cardiac disease.Inpatient detection of cardiac-inherited disease: the impact of improving family history takingArrhythmogenic Cardiomyopathy: Electrical and Structural PhenotypesNovel Genetic Variants in BAG3 and TNNT2 in a Swedish Family with a History of Dilated Cardiomyopathy and Sudden Cardiac DeathSerum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.Novel trigenic CACNA1C/DES/MYPN mutations in a family of hypertrophic cardiomyopathy with early repolarization and short QT syndrome.Exome sequencing identifies a novel mutation in the MYH6 gene in a family with early-onset sinus node dysfunction, ventricular arrhythmias, and cardiac arrestMyosin-binding Protein C Compound Heterozygous Variant Effect on the Phenotypic Expression of Hypertrophic Cardiomyopathy.The Genetic Challenges and Opportunities in Advanced Heart FailureA case of long QT syndrome: challenges on a bumpy road.
P2860
Q21146705-585FF6FD-6D9C-4982-BB53-906949316CFEQ26782057-9DC87B13-AB02-44AD-A107-9462F3F7E1B4Q26783570-DD479445-DB72-4140-ABFC-5533F1958CF3Q26827729-D7C7ABE2-7D26-43BC-82DA-5993ACE86E9BQ26852051-89027D55-B108-4F55-A374-35412BAC4F7CQ27024037-AD676263-0FED-4DC3-B227-DEAA80B448B6Q27025306-A3053717-1449-4C14-8086-02CD2654FAA8Q28074154-B84AE012-7CC3-4AA2-88C9-0D01B30984A0Q28074918-767D041C-22DE-4096-9FCE-120AFF3AE88BQ28075470-D55DB6AB-BCC5-40D4-AAAE-009A593148FFQ28080690-AC10CC96-8E94-4CB8-90FC-6C634C3B0663Q28085317-C6C25842-E2BB-406B-98B0-D71B38B1B5E8Q28087002-FE4211C1-380D-473B-A5E4-F4EA52D04D66Q28256845-0E8940B2-13AD-42D9-AF2F-34C2C45FD5D8Q28298550-94D1D1D4-09F2-4A32-B907-9AF507E28499Q28540344-D014CC82-C6C3-4A48-ABF4-4E5385E32BF6Q29465809-6E94EBBB-6E60-401F-A352-AAC2D8EC8E17Q30234301-C5EFE5F4-83CC-4DD2-B1A9-C0CED76467D1Q30238784-374975FE-3755-4B24-A0DF-7B6CBDE866DCQ33161775-DCE79169-B2D9-4744-B21F-B862BE749A00Q33162846-60C44BFD-B365-467E-8AB9-F9DCE5F2BFE3Q33163634-3DAA7A14-65C4-4C35-9414-8FCA6655FB5AQ33164381-924CE974-3E48-4992-BE00-C0D1CC66559BQ33164649-FD864F99-F832-4AF2-A8A8-25CC88A1BA97Q33164900-025EE797-12AA-4A15-825A-78FDC7610573Q33165546-595FC15F-E367-4310-A722-E78F54A8A32DQ33165566-6863AFD6-01E1-477C-B742-6C92D32CD852Q33165969-A6FEA77D-92F9-4DF2-A343-098987C7673AQ33165991-C6D14C1F-48B7-4C64-97FB-1501BE000EABQ33166380-A06DFF07-E25B-464E-A053-7E85D51A67B5Q33166777-D98B6BC5-2B37-4DEF-951D-C868264768F1Q33166859-49E0C1A5-FEA7-4BB6-8ECB-2F0B04CDA6ABQ33167672-BFE45A3B-871F-4BAA-9B26-B22BA82BB1BAQ33168824-26C0C18E-80AE-42FC-8B7C-12B89E366A72Q33554999-C0965EC2-90F6-4100-B045-82F3B8001433Q33587172-D25924F8-A459-4B62-AFBF-129FEE891D9CQ33640155-477720B3-1724-4696-9FC3-64FF86152CAEQ33647442-34010F47-0B78-4E27-B2A3-E7C15725FA96Q33653498-28352316-F378-471B-80C1-DC9ABC054B0BQ33761127-D7FDB941-5169-4A53-88FD-7948E02082DF
P2860
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
description
article cientĆfic
@ca
article scientifique
@fr
articol ČtiinČific
@ro
articolo scientifico
@it
artigo cientĆfico
@gl
artigo cientĆfico
@pt
artigo cientĆfico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artĆculo cientĆfico
@es
name
HRS/EHRA expert consensus stat ...... art Rhythm Association (EHRA).
@en
HRS/EHRA expert consensus stat ...... tween the Heart Rhythm Society
@nl
type
label
HRS/EHRA expert consensus stat ...... art Rhythm Association (EHRA).
@en
HRS/EHRA expert consensus stat ...... tween the Heart Rhythm Society
@nl
prefLabel
HRS/EHRA expert consensus stat ...... art Rhythm Association (EHRA).
@en
HRS/EHRA expert consensus stat ...... tween the Heart Rhythm Society
@nl
P2093
P50
P356
P1433
P1476
HRS/EHRA expert consensus stat ...... art Rhythm Association (EHRA).
@en
P2093
A John Camm
Charles Berul
Chris Semsarian
Christian Wolpert
Daniel P Judge
Eric Schulze-Bahr
European Heart Rhythm Association (EHRA)
Heart Rhythm Society (HRS)
HervĆØ Le Marec
Michael J Ackerman
P304
P356
10.1093/EUROPACE/EUR245
P50
P577
2011-08-01T00:00:00Z